Clinical trial

A Trial Evaluating the Blood Glucose-lowering Effect of NN1250 in Subjects With Type 2 Diabetes

NCT01154881

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-06-01

PhasePHASE1

Study timeline

Study start (unknown)2010-06-01Date precision: month

Registry last updated2017-01-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetesunresolved

Diabetes Mellitus, Type 2unresolved

Interventions

insulin degludecDRUG · verified · RxNorm: insulin degludec

Sponsors & collaborators

Novo Nordisk A/Slead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01154881 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.